amylolytic in Vietnamese

Thuộc tiêu tinh bột

Sentence patterns related to "amylolytic"

1. - AMYLOLYTIC ENZYMES ,

2. Amylolytic enzymes

3. - Amylolytic enzymes.

4. - amylolytic enzymes,

5. — Amylolytic enzymes.

6. Amylolytic enzymes meeting the requirements of Regulation (EC) No

7. Amylolytic enzymes meeting the requirements of Regulation (EC) No ...

8. Amylolytic enzymes meeting the requirements of Regulation (EC) No 1332/2008.

9. A weak amylolytic activity was found in esophagus and stomach.

10. Amylolytic enzymes meeting the requirements of Regulation (EC) No .../2008.

11. — Amylolytic enzymes meeting the requirements of Regulation (EC) No 1332/2008.

12. Amylolytic enzymes meeting the requirements of ║ Regulation (EC) No.../... [on food enzymes]

13. In this method the sample is treated with amylolytic and proteolytic enzymes.

14. – Amylolytic enzymes meeting the requirements of [the proposal for a] Regulation [.../..] on food enzymes”.

15. - Amylolytic enzymes meeting the requirements of [the proposal for a] Regulation [.../..] on food enzymes”.

16. A simple method for activity staining of pectinolytic, amylolytic and proteolytic enzymes is described.

17. The invention relates to new glycosyl hydrolases with an amylolytic activity and nucleic acids coding for said glycosyl hydrolases, a PCR-based method for identifying and preparing new glycosyl hydrolases from metagenome DNA and several possible technical uses for such glycosyl hydrolases with an amylolytic activity.

18. The increase in intracellular amylolytic enzymes was sensitive to cycloheximide and to actinomycin D indicating that enzyme induction at the level of mRNA synthesis was required.

19. Check for amylolytic activity : mix 100 ml starch solution (3.18), 5 ml buffer solution (3.4), 0 75 ml sodium chloride solution (3.5) and 62 75 mg pancreatin.

20. The amylolytic activities of the glands are decreased both after treatment for 24 hrs and when a 3 week treatment had been followed by a 2 week recuperation period.

21. Dietary fiber preparations of “cellan” type were prepared from apples, white cabbage, sugar beet pulp, soy hulls and wheat bran by treatment with amylolytic and proteolytic enzymes as well as by chemical extractions.

22. The invention relates to the use of physiologically acceptable enzyme mixtures with lipolytic, proteolytic and amylolytic activity, of microbial or animal origin, but especially to the use of digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for treating diabetes.

23. One variant of the invention relates to the use of this enzyme mixture with lipolytic, proteolytic and amylolytic activity, especially digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the adjuvant treatment of Type I and Type II Diabetes mellitus.

24. The invention also relates to sufficiently similar proteins or derivatives that exhibit amylolytic and/or CGTase activity, to the corresponding nucleic acids and micro-organisms that produce said proteins and derivatives, to methods for the production of said proteins and to diverse uses of the same.

25. Whereas the fifth indent of Article 6 (1) of Regulation (EEC) No 1570/77 defines in technical terms the minimum quality of rye used for bread-making and in respect of which the intervention agencies may apply a special increase at the time of intervention; whereas the said minimum quality depends on the amylolytic activity of the flour; whereas it is established practice to measure this minimum quality by means of a Brabender amylogram which records in conventional Brabender units (from 0 to 1 000) the maximum viscosity of the dough at a given temperature; whereas the amylogram data specified in the fifth indent of Article 6 (1) are valid only for the Brabender method, and by definition record the maximum viscosity of the dough; whereas, however, the above should be reiterated for the sake of form in Article 6 (1);